NFE2L2 and cancer: This upregulation of NRF2 in cancer cells helps them to counteract the cytotoxic effects of therapies, especially those based on the generation of ROS (e.g., radiotherapy, chemotherapy, cisplatin and doxorubicin, tamoxifen), ultimately leading to reduced treatment efficacy [103].